Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?

Date

09 Oct 2016

Session

Will there be a place for adoptive T-cell therapy in the checkpoint inhibitors?

Presenters

Jacob Schachter

Authors

J. Schachter

Author affiliations

  • Ella Institute of Melanoma, Sheba Cancer Research Center, 52621 - Tel Hashomer/IL
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings